Dexa Medica Group
CompanyROR
Trials
Bioequivalence Study of Apixaban 5 mg Film-Coated Tablet
Phase 1, Completed, 24 people, 10 Feb 2025
Collaborator, Phase 4, Active, not recruiting, 90 people, 25 Oct 2023
Phase 3, Completed, 186 people, 3 Dec 2013
Phase 3, Completed, 126 people, 13 Feb 2013
Phase 3, Completed, 124 people, 27 Nov 2012
Sources: clinicaltrials.gov